UOMO yields 2000000.00% · JNJ yields 2.13%● Live data
📍 UOMO pulled ahead of the other in Year 1
Combined, UOMO + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UOMO + JNJ for your $10,000?
UOMO Media Inc., a multi-channel entertainment company, acquires, produces, and manages entertainment content. The company operates through five divisions: UOMO Recorded Music, UOMO Talent Management, UOMO Publishing, UOMO Digital Solutions, and UOMO Film & Television. It develops recording artists, as well as markets and promotes their music through traditional, online, and mobile platforms. The company is also involved in the acquisition of rights and licensing of musical compositions from songwriters, composers, or other rights holders. In addition, it owns BasslineHQ.com, a design and software application focuses on social networking, crowd sourcing, and mobile content; and offers a solution that enables consumers to purchase tickets for concerts, events, and others through mobile devices, as well as provides online and mobile interactive applications to corporations for customer surveys, data mining, SMS, and Web alerts. Further, the company engages in film and video production activities; and the management of various entertainment clients, including label recording artists, music producers, and actors. UOMO Media Inc. was founded in 2004 and is based in Toronto, Canada.
Full UOMO Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.